Research graph
References from Living with a rare disease: Why lived experience must shape research. Local targets link to admitted publications; unresolved targets remain external evidence.
Operational description of rare diseases: a reference to improve the recognition and visibility of rare diseases
10.1186/s13023-024-03322-7 · 2024 · External reference
Melanoma in congenital melanocytic naevi
10.1111/bjd.15301 · 2017 · External reference
The role of surgery in the management of congenital melanocytic naevi in children: a perspective from Great Ormond Street Hospital
10.1016/j.bjps.2008.12.016 · 2009 · External reference
Mental health challenges and psychosocial impact of rare diseases in children and adolescents -a systematic review
10.1007/s44162-026-00207-0 · 2026 · External reference
10.70790/axuh4676
10.70790/axuh4676 · External reference
Impact of public exhibition on the perception of birthmarks
10.1111/pde.15315 · 2023 · External reference
MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children
10.1038/bjc.2017.49 · 2017 · External reference
Domains and outcomes of the core outcome set of congenital melanocytic naevi for clinical practice and research (the OCOMEN project): part 2
10.1111/bjd.20437 · 2021 · External reference
Unresolved reference
External reference
How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration
10.1186/s13023-015-0281-2 · 2015 · External reference
Data resource profile: the UK Cystic Fibrosis Registry
10.1093/ije/dyx196 · 2018 · External reference
Data analytics from Enroll-HD, a global clinical research platform for Huntington’s disease
10.1002/mdc3.12388 · 2016 · External reference
Data analytics from Enroll-HD, a global clinical research platform for Huntington’s disease
10.1002/mdc3.12388 · ExternalCitation · doi-reference
Mental health challenges and psychosocial impact of rare diseases in children and adolescents -a systematic review
10.1007/s44162-026-00207-0 · ExternalCitation · doi-reference
The role of surgery in the management of congenital melanocytic naevi in children: a perspective from Great Ormond Street Hospital
10.1016/j.bjps.2008.12.016 · ExternalCitation · doi-reference
MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children
10.1038/bjc.2017.49 · ExternalCitation · doi-reference
Data resource profile: the UK Cystic Fibrosis Registry
10.1093/ije/dyx196 · ExternalCitation · doi-reference
Melanoma in congenital melanocytic naevi
10.1111/bjd.15301 · ExternalCitation · doi-reference
Domains and outcomes of the core outcome set of congenital melanocytic naevi for clinical practice and research (the OCOMEN project): part 2
10.1111/bjd.20437 · ExternalCitation · doi-reference
Impact of public exhibition on the perception of birthmarks
10.1111/pde.15315 · ExternalCitation · doi-reference
How a patient advocacy group developed the first proposed draft guidance document for industry for submission to the U.S. Food and Drug Administration
10.1186/s13023-015-0281-2 · ExternalCitation · doi-reference
Operational description of rare diseases: a reference to improve the recognition and visibility of rare diseases
10.1186/s13023-024-03322-7 · ExternalCitation · doi-reference
10.70790/axuh4676
10.70790/axuh4676 · ExternalCitation · doi-reference
